Detroit, MINCT06960213Now EnrollingIRB Ready

Hereditary Angioedema Clinical Trial in Detroit, MI

Access cutting-edge hereditary angioedema treatment through this clinical trial at a research site in Detroit. Study-provided care at no cost to qualified participants.

Sponsored by ADARx Pharmaceuticals, Inc.

Quick Self-Assessment

See if you qualify for this Detroit location

Preparing your pre-screening questions…

Expert Care in Detroit

Access hereditary angioedema specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related hereditary angioedema treatment provided free

Apply for This Detroit Location

Check if you qualify for this hereditary angioedema clinical trial in Detroit, MI

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Detroit

    Convenient for MI residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Detroit site if eligible
  4. 4Begin participation

About This Hereditary Angioedema Study in Detroit

This study will evaluate the efficacy and safety of ADX-324 in participants with Type 1 or Type 2 hereditary angioedema. The study will also evaluate safety, pharmacokinetics (PK), pharmacodynamics (PD), and health-related quality of life measures.

Sponsor: ADARx Pharmaceuticals, Inc.

Who Can Participate

Inclusion Criteria

Age ≥18 years at the time of signing informed consent.
Have a documented diagnosis of HAE-1/HAE-2 (Type I or II)
Experience ≥1 Investigator-confirmed HAE attack in the first 4 weeks of Screening or ≥2 Investigator-confirmed HAE attacks in 8 weeks of Screening
Able to use at least one acute therapy to treat HAE attacks (such as a plasma-derived or recombinant C1-INH concentrate or a BK2-receptor antagonist) Key

Exclusion Criteria

Concurrent diagnosis of another form of recurrent angioedema (such as acquired angioedema, HAE with normal C1-INH (previously known as HAE Type III), idiopathic angioedema, or recurrent angioedema associated with urticaria).
Any clinically significant renal disease
Any clinically significant hepatic disease
Have used any of the following for long-term prevention of HAE attacks:
C1-INH agent (CINRYZE, HAEGARDA, RUCONEST) within 2 weeks prior to Screening.
Berotralstat (ORLADEYO) within 3 weeks prior to Screening.
Lanadelumab (TAKHZYRO) within 8 weeks prior to the Screening.
Androgen use within 12 weeks prior to Screening.
Received prior treatment with any RNA/DNA-based therapy for HAE or intolerant to any prior RNA/DNA-based therapy for any condition, excluding vaccines.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Detroit?

Yes, this clinical trial (NCT06960213) has an active research site in Detroit, MI that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Hereditary Angioedema Treatment Options in Detroit, MI

If you're searching for hereditary angioedema treatment options in Detroit, MI, this clinical trial (NCT06960213) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Detroit research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hereditary angioedema specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all hereditary angioedema clinical trials near you to find additional studies recruiting in your area.

More Erectile Dysfunction Trials in Detroit, MI

See all erectile dysfunction clinical trials recruiting in Detroit — not just this study.

Browse Erectile Dysfunction Trials in Detroit →

Browse More Trials by Condition

Erectile Dysfunction TrialsHereditary Angioedema TrialsUrticaria TrialsAll Conditions →

Ready to Join in Detroit?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Detroit, MI